These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6143140)

  • 21. Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry.
    Meunier PJ; Chapuy MC; Delmas P; Charhon S; Edouard C; Arlot M
    Am J Med; 1987 Feb; 82(2A):71-8. PubMed ID: 3103438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pseudosarcomatous osteolysis in a Paget's disease patient treated with disodium etidronate (EHDP)].
    Rondier J; Huchet B; Cayla J
    Rev Rhum Mal Osteoartic; 1984 Jan; 51(1):49-54. PubMed ID: 6420876
    [No Abstract]   [Full Text] [Related]  

  • 23. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 24. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
    Mautalen C; Gonzalez D; Blumenfeld EL; Santini Araujo E; Schajowicz F
    Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mineralisation defects with pamidronate therapy for Paget's disease.
    Adamson BB; Gallacher SJ; Byars J; Ralston SH; Boyle IT; Boyce BF
    Lancet; 1993 Dec; 342(8885):1459-60. PubMed ID: 7902484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of disodium etidronate on Paget's disease of bone.
    Muir HG; Schabort I; Hough FS
    S Afr Med J; 1987 Oct; 72(7):470-2. PubMed ID: 3116683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR; Bijvoet OL
    Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone.
    Meunier PJ; Chapuy MC; Alexandre C; Bressot C; Edouard C; Vignon C; Mathieu L; Trechsel U
    Lancet; 1979 Sep; 2(8141):489-92. PubMed ID: 90215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M; Khairi A; Johnston C
    Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
    [No Abstract]   [Full Text] [Related]  

  • 30. Diphosphonates in Paget's disease.
    Russell RG; Smith R; Preston C; Walton RJ; Woods CG
    Lancet; 1974 May; 1(7863):894-8. PubMed ID: 4133419
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate].
    Ravault A; Meunier PJ
    Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):293-302. PubMed ID: 2496461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of etidronate (EHDP) in Paget's disease of bone.
    Johnston CC; Khairi MR; Meunier PJ
    Arthritis Rheum; 1980 Oct; 23(10):1172-6. PubMed ID: 6775643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etidronate disodium for Paget's disease.
    Med Lett Drugs Ther; 1978 Sep; 20(18):78-9. PubMed ID: 99647
    [No Abstract]   [Full Text] [Related]  

  • 34. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).
    Johnston CC; Altman RD; Canfield RE; Finerman GA; Taulbee JD; Ebert ML
    Clin Orthop Relat Res; 1983; (172):186-94. PubMed ID: 6401608
    [No Abstract]   [Full Text] [Related]  

  • 35. Quantitative bone histology in Paget's disease of bone: influence of sodium etidronate (EHDP) therapy.
    Khairi MR; Meunier P; Edouard C; Courpron P; Bernard J; DeRosa GP; Johnston CC
    Calcif Tissue Res; 1977 May; 22 Suppl():355-8. PubMed ID: 410484
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR
    N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract]   [Full Text] [Related]  

  • 37. Risedronate, a highly effective, short-term oral treatment for Paget's disease: a dose-response study.
    Brown JP; Hosking DJ; Ste-Marie L; Johnston CC; Reginster J; Ryan WG; Johnson TD; Bekker PJ
    Calcif Tissue Int; 1999 Feb; 64(2):93-9. PubMed ID: 9914313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic radiologic patterns of Paget's disease of bone.
    Maldague B; Malghem J
    Clin Orthop Relat Res; 1987 Apr; (217):126-51. PubMed ID: 3103963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose pamidronate in the management of resistant Paget's disease.
    Cundy T; Wattie D; King AR
    Calcif Tissue Int; 1996 Jan; 58(1):6-8. PubMed ID: 8825232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of Paget's disease with low dose sodium etidronate (5mg/kg/day). Occurrence of reversible transient suspected leukopenia].
    Reginster JY; Gritten C; Diverse P; Hauwaert PC; Crielaard JM; Halleux R; Franchimont P
    Rev Rhum Mal Osteoartic; 1985 Mar; 52(3):145-50. PubMed ID: 3923603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.